Report Detail

Request for Sample of this report

Chemical & Material Global 10-DAB III Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4721799
    • |
  • 16 July, 2026
    • |
  • Global
    • |
  • 107 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global 10-DAB III market size was valued at US$ 81.29 million in 2025 and is forecast to a readjusted size of US$ 153 million by 2032 with a CAGR of 9.5% during review period.
10‑DAB III, full name 10‑Deacetylbaccatin III, is a natural tetracyclic diterpenoid taxane extracted from Taxus twigs and leaves. It appears as off-white crystalline powder, poorly soluble in water but soluble in common organic solvents. As a core pharmaceutical intermediate, it is the key starting material for semi-synthesis of Paclitaxel, Docetaxel and Cabazitaxel, three mainstream anti-cancer APIs. Besides bulk drug manufacturing, it is also widely applied in novel taxane derivative research and pharmaceutical reference standard preparation.The price of pharmaceutical-grade 10‑DAB III (≥98% HPLC) fluctuates between 1800–3200 US dollars per kilogram, affected by raw material yield, extraction cost and global market demand. Its industrial chain starts from Taxus cultivation and raw leaf harvesting in China and India, followed by plant extraction, purification and fine refinement at professional manufacturers including South Pharmaceutical, Alchem and Yunnan Hande. After finished intermediate production, 10‑DAB III is globally traded to pharmaceutical factories for semi-synthesis of Paclitaxel, Docetaxel and Cabazitaxel bulk drugs. Downstream finished anticancer medicines are then processed into injections for worldwide clinical use. Emerging R&D demand for taxane ADC drugs also steadily lifts long-term market consumption of this core intermediate.
Market Driving Factors
Sustained clinical demand for anti-cancer medicines
Paclitaxel, Docetaxel and Cabazitaxel remain essential first-line chemotherapy drugs for multiple malignant tumors worldwide. Stable global sales of finished anticancer drugs create steady basic procurement demand for 10-DAB III as their core semi-synthetic intermediate.
Advancing development of novel taxane derivatives and ADC drugs
Growing R&D investment in antibody-drug conjugates and innovative taxane anti-tumor agents expands downstream application scenarios, generating incremental consumption of high-purity 10-DAB III.
Expansion of mature generic drug market globally
Mass approval of generic versions of paclitaxel-series APIs in emerging pharmaceutical markets boosts bulk purchase of standard-grade 10-DAB III and fuels overall market volume growth.
Advantages of plant extraction industrialization in China and India
Large-scale Taxus planting and mature extraction & purification technologies in China and India guarantee stable raw material supply, lower comprehensive production cost and promote global market popularization of plant-derived 10-DAB III.
Strict restriction on wild Taxus resource exploitation
Regulatory bans on wild Taxus harvesting push standardized cultivated Taxus as exclusive raw material source, stabilizing orderly supply pattern of formal qualified manufacturers.
Market Challenges
Unstable yield fluctuation of Taxus raw material
Taxus growth cycle is long, climate change, planting scale adjustment directly affect leaf output, causing periodic raw material price volatility and impacting production cost of 10-DAB III.
High purification technical threshold for high-pharma-grade products
High-end 98% and above purity products require sophisticated refining process and precision testing equipment; core purification technologies are concentrated in leading enterprises, raising R&D investment for new market participants.
Intensified low-end price competition among manufacturers
Excess low-purity crude intermediate capacity triggers vicious price competition, squeezing gross profit space of regular manufacturers producing qualified pharmaceutical-grade 10-DAB III.
Strict quality certification and long downstream qualification audit
Products for overseas API factories need DMF, pharmacopoeia compliance certification; downstream pharmaceutical customers carry out lengthy supplier qualification verification, delaying new supplier order access.
Alternative biosynthetic process industrialization impact
Cell culture and biosynthesis routes for 10-DAB III are gradually industrialized; mature alternative technology in the future will bring substitution pressure to traditional plant extraction manufacturers.
This report is a detailed and comprehensive analysis for global 10-DAB III market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global 10-DAB III market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global 10-DAB III market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global 10-DAB III market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global 10-DAB III market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for 10-DAB III
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global 10-DAB III market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Phyton Biotech, Deccan Nutraceuticals, Alchem International, Indena, South Pharmaceutical, Sai Phytoceuticals, Sarv Biolabs Pvt, Aphios, Taxus Pharma, Yunnan Hande, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
10-DAB III market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
≥98%
≥95%
Others
Market segment by Production Source
Natural Extraction
Cell Culture/Fermentation Source
Semi-synthetic/Conversion Method
Market segment by Impurity Control Level
Pharmacopoeia Grade
High Purity Grade
Industrial Grade
Market segment by Application
Production of Docetaxel
Production of Paclitaxel
Others
Major players covered
Phyton Biotech
Deccan Nutraceuticals
Alchem International
Indena
South Pharmaceutical
Sai Phytoceuticals
Sarv Biolabs Pvt
Aphios
Taxus Pharma
Yunnan Hande
Kavya Pharma
Jinhe
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 10-DAB III product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of 10-DAB III, with price, sales quantity, revenue, and global market share of 10-DAB III from 2021 to 2026.
Chapter 3, the 10-DAB III competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 10-DAB III breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and 10-DAB III market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of 10-DAB III.
Chapter 14 and 15, to describe 10-DAB III sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global 10-DAB III Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 ≥98%
    • 1.3.3 ≥95%
    • 1.3.4 Others
  • 1.4 Market Analysis by Production Source
    • 1.4.1 Overview: Global 10-DAB III Consumption Value by Production Source: 2021 Versus 2025 Versus 2032
    • 1.4.2 Natural Extraction
    • 1.4.3 Cell Culture/Fermentation Source
    • 1.4.4 Semi-synthetic/Conversion Method
  • 1.5 Market Analysis by Impurity Control Level
    • 1.5.1 Overview: Global 10-DAB III Consumption Value by Impurity Control Level: 2021 Versus 2025 Versus 2032
    • 1.5.2 Pharmacopoeia Grade
    • 1.5.3 High Purity Grade
    • 1.5.4 Industrial Grade
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global 10-DAB III Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Production of Docetaxel
    • 1.6.3 Production of Paclitaxel
    • 1.6.4 Others
  • 1.7 Global 10-DAB III Market Size & Forecast
    • 1.7.1 Global 10-DAB III Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global 10-DAB III Sales Quantity (2021-2032)
    • 1.7.3 Global 10-DAB III Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Phyton Biotech
    • 2.1.1 Phyton Biotech Details
    • 2.1.2 Phyton Biotech Major Business
    • 2.1.3 Phyton Biotech 10-DAB III Product and Services
    • 2.1.4 Phyton Biotech 10-DAB III Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Phyton Biotech Recent Developments/Updates
  • 2.2 Deccan Nutraceuticals
    • 2.2.1 Deccan Nutraceuticals Details
    • 2.2.2 Deccan Nutraceuticals Major Business
    • 2.2.3 Deccan Nutraceuticals 10-DAB III Product and Services
    • 2.2.4 Deccan Nutraceuticals 10-DAB III Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Deccan Nutraceuticals Recent Developments/Updates
  • 2.3 Alchem International
    • 2.3.1 Alchem International Details
    • 2.3.2 Alchem International Major Business
    • 2.3.3 Alchem International 10-DAB III Product and Services
    • 2.3.4 Alchem International 10-DAB III Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Alchem International Recent Developments/Updates
  • 2.4 Indena
    • 2.4.1 Indena Details
    • 2.4.2 Indena Major Business
    • 2.4.3 Indena 10-DAB III Product and Services
    • 2.4.4 Indena 10-DAB III Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Indena Recent Developments/Updates
  • 2.5 South Pharmaceutical
    • 2.5.1 South Pharmaceutical Details
    • 2.5.2 South Pharmaceutical Major Business
    • 2.5.3 South Pharmaceutical 10-DAB III Product and Services
    • 2.5.4 South Pharmaceutical 10-DAB III Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 South Pharmaceutical Recent Developments/Updates
  • 2.6 Sai Phytoceuticals
    • 2.6.1 Sai Phytoceuticals Details
    • 2.6.2 Sai Phytoceuticals Major Business
    • 2.6.3 Sai Phytoceuticals 10-DAB III Product and Services
    • 2.6.4 Sai Phytoceuticals 10-DAB III Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sai Phytoceuticals Recent Developments/Updates
  • 2.7 Sarv Biolabs Pvt
    • 2.7.1 Sarv Biolabs Pvt Details
    • 2.7.2 Sarv Biolabs Pvt Major Business
    • 2.7.3 Sarv Biolabs Pvt 10-DAB III Product and Services
    • 2.7.4 Sarv Biolabs Pvt 10-DAB III Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Sarv Biolabs Pvt Recent Developments/Updates
  • 2.8 Aphios
    • 2.8.1 Aphios Details
    • 2.8.2 Aphios Major Business
    • 2.8.3 Aphios 10-DAB III Product and Services
    • 2.8.4 Aphios 10-DAB III Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Aphios Recent Developments/Updates
  • 2.9 Taxus Pharma
    • 2.9.1 Taxus Pharma Details
    • 2.9.2 Taxus Pharma Major Business
    • 2.9.3 Taxus Pharma 10-DAB III Product and Services
    • 2.9.4 Taxus Pharma 10-DAB III Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Taxus Pharma Recent Developments/Updates
  • 2.10 Yunnan Hande
    • 2.10.1 Yunnan Hande Details
    • 2.10.2 Yunnan Hande Major Business
    • 2.10.3 Yunnan Hande 10-DAB III Product and Services
    • 2.10.4 Yunnan Hande 10-DAB III Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Yunnan Hande Recent Developments/Updates
  • 2.11 Kavya Pharma
    • 2.11.1 Kavya Pharma Details
    • 2.11.2 Kavya Pharma Major Business
    • 2.11.3 Kavya Pharma 10-DAB III Product and Services
    • 2.11.4 Kavya Pharma 10-DAB III Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Kavya Pharma Recent Developments/Updates
  • 2.12 Jinhe
    • 2.12.1 Jinhe Details
    • 2.12.2 Jinhe Major Business
    • 2.12.3 Jinhe 10-DAB III Product and Services
    • 2.12.4 Jinhe 10-DAB III Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Jinhe Recent Developments/Updates

3 Competitive Environment: 10-DAB III by Manufacturer

  • 3.1 Global 10-DAB III Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global 10-DAB III Revenue by Manufacturer (2021-2026)
  • 3.3 Global 10-DAB III Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of 10-DAB III by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 10-DAB III Manufacturer Market Share in 2025
    • 3.4.3 Top 6 10-DAB III Manufacturer Market Share in 2025
  • 3.5 10-DAB III Market: Overall Company Footprint Analysis
    • 3.5.1 10-DAB III Market: Region Footprint
    • 3.5.2 10-DAB III Market: Company Product Type Footprint
    • 3.5.3 10-DAB III Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global 10-DAB III Market Size by Region
    • 4.1.1 Global 10-DAB III Sales Quantity by Region (2021-2032)
    • 4.1.2 Global 10-DAB III Consumption Value by Region (2021-2032)
    • 4.1.3 Global 10-DAB III Average Price by Region (2021-2032)
  • 4.2 North America 10-DAB III Consumption Value (2021-2032)
  • 4.3 Europe 10-DAB III Consumption Value (2021-2032)
  • 4.4 Asia-Pacific 10-DAB III Consumption Value (2021-2032)
  • 4.5 South America 10-DAB III Consumption Value (2021-2032)
  • 4.6 Middle East & Africa 10-DAB III Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global 10-DAB III Sales Quantity by Type (2021-2032)
  • 5.2 Global 10-DAB III Consumption Value by Type (2021-2032)
  • 5.3 Global 10-DAB III Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global 10-DAB III Sales Quantity by Application (2021-2032)
  • 6.2 Global 10-DAB III Consumption Value by Application (2021-2032)
  • 6.3 Global 10-DAB III Average Price by Application (2021-2032)

7 North America

  • 7.1 North America 10-DAB III Sales Quantity by Type (2021-2032)
  • 7.2 North America 10-DAB III Sales Quantity by Application (2021-2032)
  • 7.3 North America 10-DAB III Market Size by Country
    • 7.3.1 North America 10-DAB III Sales Quantity by Country (2021-2032)
    • 7.3.2 North America 10-DAB III Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe 10-DAB III Sales Quantity by Type (2021-2032)
  • 8.2 Europe 10-DAB III Sales Quantity by Application (2021-2032)
  • 8.3 Europe 10-DAB III Market Size by Country
    • 8.3.1 Europe 10-DAB III Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe 10-DAB III Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific 10-DAB III Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific 10-DAB III Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific 10-DAB III Market Size by Region
    • 9.3.1 Asia-Pacific 10-DAB III Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific 10-DAB III Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America 10-DAB III Sales Quantity by Type (2021-2032)
  • 10.2 South America 10-DAB III Sales Quantity by Application (2021-2032)
  • 10.3 South America 10-DAB III Market Size by Country
    • 10.3.1 South America 10-DAB III Sales Quantity by Country (2021-2032)
    • 10.3.2 South America 10-DAB III Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa 10-DAB III Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa 10-DAB III Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa 10-DAB III Market Size by Country
    • 11.3.1 Middle East & Africa 10-DAB III Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa 10-DAB III Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 10-DAB III Market Drivers
  • 12.2 10-DAB III Market Restraints
  • 12.3 10-DAB III Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of 10-DAB III and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of 10-DAB III
  • 13.3 10-DAB III Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 10-DAB III Typical Distributors
  • 14.3 10-DAB III Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on 10-DAB III. Industry analysis & Market Report on 10-DAB III is a syndicated market report, published as Global 10-DAB III Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of 10-DAB III market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo